In support of this hypothesis, we previously demonstrated that a single intravenously administered injection of enzymatically inactive tPA not only neutralizes LPS toxicity but also significantly reverses inflammation and disease progression in the dextran sodium sulfate model of inflammatory bowel disease (42, 59). Here, PLAT is linked to inflammatory bowel disease.